LncRNA MEG3 repressed malignant melanoma progression via inactivating Wnt signaling pathway

Journal of Cellular Biochemistry
Peng LiPeng Yao

Abstract

Accumulating evidence has indicated that MEG3 can serve as a tumor suppressive lncRNA in various tumors. It is aberrantly expressed in multiple cancers. However, the biological roles of MEG3 in melanoma are poorly understood. Therefore, in our study, we concentrated on the biological mechanism of MEG3 in melanoma progression. First, we observed that MEG3 was obviously decreased in melanoma cells including A375, SK-MEL-1, B16, and A2058 cells compared to human epidermal melanocytes HEMa-LP. MEG3 was restored by transfecting LV-MEG3 in to A375 and A2058 cells. Subsequently, we found that overexpression of MEG3 was able to inhibit cell proliferation and colony formation capacity. Meanwhile, melanoma cell apoptosis was induced by up-regulation of MEG3. Overexpression of MEG3 greatly repressed melanoma cell migration and invasion ability. In addition, Wnt signaling pathway has been identified in the progression of various cancers. Here, in our study, it was indicated that Wnt signaling was highly activated in melanoma cells with β-catenin expression significantly increased and GSK-3β decreased. Interestingly, MEG restoration strongly inactivated Wnt signaling pathway by reducing β-catenin and CyclinD1, elevating GSK-3β levels in vit...Continue Reading

References

Jan 24, 2004·Cancer Biology & Therapy·Louise R Howe, Anthony M C Brown
Apr 14, 2006·Mayo Clinic Proceedings·Deborah L CumminsArjun Chanmugam
Feb 23, 2007·Nature·Vanessa Gray-SchopferRichard Marais
Jul 22, 2009·Developmental Cell·Bryan T MacDonaldXi He
Oct 13, 2011·Nature Reviews. Genetics·Mary Muers
Mar 7, 2012·Journal of Molecular Endocrinology·Yunli ZhouAnne Klibanski
Mar 10, 2012·Journal of Mammary Gland Biology and Neoplasia·Amy N ShoreJeffrey M Rosen
Nov 27, 2015·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Gang LuoGuosong Jiang
Feb 5, 2016·Biochimica Et Biophysica Acta·Jasmina PaluncicDes R Richardson
Jul 30, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Qingyun GuoLili Huang
Oct 21, 2016·Pigment Cell & Melanoma Research·Eleonora LeucciKeith W Vance
Sep 13, 2016·Oncogene·T ZhanM Boutros
Nov 2, 2016·International Journal of Molecular Sciences·Jia HuoDingwei Zhang
Apr 19, 2017·Oncotarget·Eva HulstaertPieter Mestdagh
May 4, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Wei ZhangFeng Ren
Jun 28, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hui Zhang, Xuanfu Xu
Nov 14, 2017·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Yuan-Yuan Zhang, Hao-Miao Feng
Dec 16, 2017·The Biochemical Journal·Ondrej SlabyOndrej Sedlacek
Jan 18, 2018·Cancer Letters·Liang ChenGe Shan
Jan 20, 2018·Journal of Cancer Research and Clinical Oncology·Wenkang LuanBin Xu

❮ Previous
Next ❯

Citations

Jun 14, 2019·Frontiers in Genetics·Le Ou-YangZexuan Zhu
Jun 4, 2021·Molecular Oncology·Barbara MonticoElisabetta Fratta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.